Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain
The first Canadian case of COVID-19 was reported in January 2020. Community transmission was confirmed in March 2020, and rapid closure of daycares, schools, workplaces, and nonessential services occurred to varying degrees across the Canadian provinces and territories.
Restrictions to private and public gatherings in addition to the closure of regional/provincial/ national/international borders were also put in place. The biopsychosocial effects of the COVID-19 pandemic are important in the general population and affect disproportionately high-risk and vulnerable individuals such as those living with chronic diseases, older adults, and socially and economically deprived populations.